mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α
Guangchao Cao(Jinan University), Zhinan Yin(Translational Research Institute), Jiyu Tong(Sichuan University), Wanjun Huang(Jinan University), Hengwen Yang(Jinan University), Yanqiong Jia(Jinan University), Hongbo Chi(St. Jude Children's Research Hospital), Jun Wei(Jilin Medical University), Hui Liu(Shanghai University), Qian Wang(Fourth People’s Hospital of Jinan), Zhenhua Wu(Zhejiang Chinese Medical University), Liqing Zhao(Shenzhen University), Ziyu Meng(Capital Medical University), Zonghua Liu(Jinan University), Guangqiang Li(Jinan University), Jianlei Hao(Nankai University)
Cited by 34
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Regulation and function of mTOR signalling in T cell fate decisions
|Nature reviews. Immunology|2012|996
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928